Cargando…
Another case of autoimmune hepatitis after SARS-CoV-2 vaccination – still casualty?
Autores principales: | Londoño, Maria-Carlota, Gratacós-Ginès, Jordi, Sáez-Peñataro, Joaquín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197609/ https://www.ncbi.nlm.nih.gov/pubmed/34129886 http://dx.doi.org/10.1016/j.jhep.2021.06.004 |
Ejemplares similares
-
Another casualty of the SARS-CoV-2 pandemic—the environmental impact
por: Gonçalves, Letícia Rocha, et al.
Publicado: (2021) -
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?
por: Bril, Fernando, et al.
Publicado: (2021) -
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?”
por: Capecchi, Pier Leopoldo, et al.
Publicado: (2021) -
Reply to: “Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?””
por: Bril, Fernando, et al.
Publicado: (2021) -
Is the tuberculosis response another casualty of COVID-19?
por: The Lancet Microbe
Publicado: (2021)